Triple GLP-1 / GIP / Glucagon Receptor Agonist (CAS 2381089-83-2) Compound Name: Research Peptide (CAS 2381089-83-2) Classification: Research Peptide Multi-Receptor Agonist Description: This compound is a synthetic research peptide that functions as a triple agonist of the glucagon receptor (GCGR), glucose dependent insulinotropic polypeptide receptor (GIPR), and glucagon like peptide-1 receptor (GLP-1R)
Maltodextrin or other carbohydrate-based fillers
Natural approaches through whole foods and lifestyle modifications are generally safe but should not replace prescribed medications for type 2 diabetes or obesity
Mitochondrial GSH transport (via SLC25A39) and the Nrf2-ARE regulatory pathway constitute key regulatory mechanisms at the tissue/cellular level, ensuring that GSH metabolism adapts to different physiological and pathological states
Although for me, its less about trying to manage a health problem and more about trying to restructure my body
And then the last thing Ill note, too, is theres a lot of serious, like, gastrointestinal side effects, and that kind of harkens back to the, you know, people quitting after two years, so